Research
Our goals are to advance research and to complement the efforts of the NIH and other agencies. NephCure and friends have committed over $13M to research.
Clinical Trials
Find and enroll in clinical trials and studies. Help researchers develop better treatments and discover causes for FSGS and Nephrotic Syndrome.
Take our confidential patient survey
Help us understand what you are going through and how we can best support you. Click here
Featured Researcher
Michael Gregory Janech, Ph.D.
Medical University of South Carolina, Dept. of Medicine, Div. of Nephrology
Read more
Education
NephCure’s Lunch & Learns provide patients and their families with the latest information on research, allow you to ask questions of medical professionals and meet other families affected by these conditions.
Our Stories
Nicolette's Story
I was a second year student at the time I started having problems with my kidney. I didn’t drink or smoke and I lived a very active lifestyle. It came as a shock when I was diagnosed with Nephrotic Syndrome. In 2009, during my second semester...
To read this and other personal stories, click here.
NephSpace
Join NephCure's FSGS & Nephrotic Syndrome Support Community NephSpace. Interact with patients and families and share your concerns, hopes and personal stories. Click Here
The NephCure Walk
Join a NephCure Team and walk with us to raise funds and awareness for FSGS and Nephrotic Syndrome.
Click here for locations.
Text Updates
We will text you with upcoming events & opportunities. Enter your mobile phone number HERE to receive a text message update 1 time per week from NephCure. You may also text "kidney" to 51555 on your mobile phone.
New To NephCure?
Just in from Facebook
Events Calendar
View our online Events Calendar to find an event near you. Or, contact our Grassroots Team by calling 610 540 0186 x21 or emailing mail:cliberatore@nephcure.org
NephCure Canada
NephCure is also in Canada! Follow this page to learn more about our Canadian activities, including: walks, Lunch & Learn seminars and more.
